Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucine Vuitton

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
United European Gastroenterology Journal|March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAIDLouis Calméjane, Catherine Reenaers, Claire Gay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Journal of Crohn'S & Colitis|April 25, 2025
Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFEDSophie Geyl, Jérémie Jacques, Alicia Anneraud, et al.
Rheumatology (Oxford, England)|August 24, 2021
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockersCamille Rasmussen, Vered Abitbol, Khalil El Karoui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2025
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMissionNicolas Mathieu, Marianne Hupé, Frédéric Heluwaert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 31, 2020
Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter studyDiane Bruyere, Franck Monnien, Prudence Colpart, et al.
Clinics and Research in Hepatology and Gastroenterology|June 6, 2026
Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAIDAurelien Amiot, Axel Ahres, Carmen Stefanescu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2025
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional studyLucile Fontaine, Philippe Seksik, Carmen Stefanescu, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
United European Gastroenterology Journal|March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAIDLouis Calméjane, Catherine Reenaers, Claire Gay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Journal of Crohn'S & Colitis|April 25, 2025
Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFEDSophie Geyl, Jérémie Jacques, Alicia Anneraud, et al.
Rheumatology (Oxford, England)|August 24, 2021
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockersCamille Rasmussen, Vered Abitbol, Khalil El Karoui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2025
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMissionNicolas Mathieu, Marianne Hupé, Frédéric Heluwaert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 31, 2020
Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter studyDiane Bruyere, Franck Monnien, Prudence Colpart, et al.
Clinics and Research in Hepatology and Gastroenterology|June 6, 2026
Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAIDAurelien Amiot, Axel Ahres, Carmen Stefanescu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2025
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional studyLucile Fontaine, Philippe Seksik, Carmen Stefanescu, et al.
Pageof 12